Reproductive Considerations for Patients with Early-Onset Breast Cancer.

IF 1 Q4 ONCOLOGY Current Breast Cancer Reports Pub Date : 2022-06-01 Epub Date: 2022-04-11 DOI:10.1007/s12609-022-00445-3
Versha Pleasant, Nicole Ulrich, Mark D Pearlman, Molly B Moravek
{"title":"Reproductive Considerations for Patients with Early-Onset Breast Cancer.","authors":"Versha Pleasant, Nicole Ulrich, Mark D Pearlman, Molly B Moravek","doi":"10.1007/s12609-022-00445-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose of review: </strong>Early-onset breast cancer presents various challenges in regard to reproductive health. This review examines the current data pertaining to issues such as fertility preservation, preimplantation genetics, the impact of chemotherapy and endocrine therapy, contraception, and pregnancy in the young breast cancer population.</p><p><strong>Recent findings: </strong>Many breast cancer treatments such as chemotherapy and endocrine therapy can be gonadotoxic or teratogenic. Multiple fertility preservation options are now available to young breast cancer patients, including embryo and oocyte preservation, ovarian tissue preservation, and ovarian suppression with GnRH agonists. In patients with known cancer germline mutations, preimplantation genetic testing is an option.</p><p><strong>Summary: </strong>Fertility preservation and other reproductive services are expanding and offer great promise to the early-onset breast cancer community. Providers must be knowledgeable about the various options in order to better empower patients.</p>","PeriodicalId":10769,"journal":{"name":"Current Breast Cancer Reports","volume":"14 1","pages":"37-45"},"PeriodicalIF":1.0000,"publicationDate":"2022-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11548833/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Breast Cancer Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12609-022-00445-3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose of review: Early-onset breast cancer presents various challenges in regard to reproductive health. This review examines the current data pertaining to issues such as fertility preservation, preimplantation genetics, the impact of chemotherapy and endocrine therapy, contraception, and pregnancy in the young breast cancer population.

Recent findings: Many breast cancer treatments such as chemotherapy and endocrine therapy can be gonadotoxic or teratogenic. Multiple fertility preservation options are now available to young breast cancer patients, including embryo and oocyte preservation, ovarian tissue preservation, and ovarian suppression with GnRH agonists. In patients with known cancer germline mutations, preimplantation genetic testing is an option.

Summary: Fertility preservation and other reproductive services are expanding and offer great promise to the early-onset breast cancer community. Providers must be knowledgeable about the various options in order to better empower patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症早期发病患者的生殖因素
审查目的:早发乳腺癌给生殖健康带来了各种挑战。本综述研究了与年轻乳腺癌患者生育力保存、植入前遗传学、化疗和内分泌治疗的影响、避孕和怀孕等问题相关的现有数据:最近的研究结果:许多乳腺癌治疗方法,如化疗和内分泌治疗,都可能具有性腺毒性或致畸性。目前,年轻乳腺癌患者可选择多种生育力保存方法,包括胚胎和卵母细胞保存、卵巢组织保存以及使用 GnRH 激动剂进行卵巢抑制。对于已知癌症种系突变的患者,可以选择植入前基因检测:摘要:生育力保存和其他生殖服务正在不断扩大,为早发性乳腺癌患者提供了巨大的希望。医疗服务提供者必须了解各种选择,以便更好地增强患者的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
24
期刊介绍: This journal aims to review the most important, recently published clinical findings related to the diagnosis, treatment, management, and prevention of breast cancer. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care of those with the disease. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas, such as prevention, systemic therapy, and translational research. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also provided.
期刊最新文献
Clinical Relevance of Radial Scars: A Review of the Current Literature Minimally Invasive Breast Cancer: How to Find Early Breast Cancers Impact of Systemic Therapy on Fertility in Women with Early-Stage Breast Cancer Chemoprevention—Historical Perspectives and Current Trends Hereditary Breast Cancer, Genetics, and Fertility Preservation
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1